Funding Opportunity PAS-21-216 from the NIH Guide for Grants and Contracts. The primary objective of this FOA is to solicit research projects with the aim of elucidating the role of positive affect and related processes in suicidal individuals and evaluating modifiable behavioral and neural targets. Specifically, studies should include clinical populations with high risk of suicide, suicide attempters or acutely suicidal individuals, and may also include non-suicidal patients, high risk individuals in an absence of diagnosis, or healthy control groups. Projects across developmental spectrum are encouraged. Research projects should aim to 1) specify a construct of interest either in terms of research domain criteria: positive valence system (RDoC PVS), or a symptom relevant construct, such as an anhedonia/ anhedonia subtype, cognitive process such as present/future reward decision making, generating reasons for living in the context of anticipation of positive experiences, etc. 2) demonstrate that measures of the construct are reliable and reproducible and engage brain subsystem relevant to positive affect, and/or 3) show active modification of targeted brain system and behavioral measures of the construct through behavioral training or other means such as use of non-invasive neuromodulation, pharmacological or psychosocial therapeutic probes. Behavioral tasks used may include both novel and established tasks within the RDoC positive valence domain (e.g. reward sensitivity, reward valuation, and reward learning) and/or tasks probing components and subconstructs of hedonic and related processes. Use of measures of the dynamic changes in PA is strongly encouraged to further establish co-occurrence with other risk factors and suicidality.

Funding Opportunity PAS-21-215 from the NIH Guide for Grants and Contracts. The primary objective of this FOA is to solicit research projects with the aim of elucidating the role of positive affect and related processes in suicidal individuals and evaluating modifiable behavioral and neural targets. Specifically, studies should include clinical populations with high risk of suicide, suicide attempters or acutely suicidal individuals, and may also include non-suicidal patients, high risk individuals in an absence of diagnosis, or healthy control groups. Projects across developmental spectrum are encouraged. Research projects should aim to 1) specify a construct of interest either in terms of research domain criteria: positive valence system (RDoC PVS), or a symptom relevant construct, such as an anhedonia/ anhedonia subtype, cognitive process such as present/future reward decision making, generating reasons for living in the context of anticipation of positive experiences, etc. 2) demonstrate that measures of the construct are reliable and reproducible and engage brain subsystem relevant to positive affect, and/or 3) show active modification of targeted brain system and behavioral measures of the construct through behavioral training or other means such as use of non-invasive neuromodulation, pharmacological or psychosocial therapeutic probes. Behavioral tasks used may include both novel and established tasks within the RDoC positive valence domain (e.g. reward sensitivity, reward valuation, and reward learning) and/or tasks probing components and subconstructs of hedonic and related processes. Use of measures of the dynamic changes in PA is strongly encouraged to further establish co-occurrence with other risk factors and suicidality.

£37,104-£44,448: Wellcome Sanger Institute: The Opportunity: We are seeking an enthusiastic and motivated Research Administrator to provide operational and research admin support to Open Targ... Hinxton, Cambridgeshire

Notice NOT-AA-21-014 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HD-22-018 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite SBIR applications to support and facilitate the development of new and/or improved clinical biomarkers and companion biomarker diagnostics (e.g., point of care and/or direct-to-consumer tests, DTC) to support the clinical development of non-hormonal contraceptive product(s) for men and women.

Notice NOT-AA-21-013 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-186 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Research Experiences

Notice NOT-DA-21-041 from the NIH Guide for Grants and Contracts

EUR 3,945,90 (following the recommendations of FWF): CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences: Are you interested in evaluating the impact of genetic variations in human transporters? Do you want to join..... Vienna (AT)

Competitive Salary: EMBL: About this position Working as part of Ensembl Genebuild, you will join a team Bioinformaticians and Developers who are experts in gene structure a Hinxton, Cambridgeshire, England

Notice NOT-OD-21-106 from the NIH Guide for Grants and Contracts

“We are all stronger if we authentically share and connect with one another,” this grad student writes.

Notice NOT-CA-21-055 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-043 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MD-21-008 from the NIH Guide for Grants and Contracts. NIMHD invites applications from eligible institutions to establish a Research Coordinating Center (RCC) to support comprehensive research centers on prevention, treatment, and management of co-occurring chronic diseases associated with health disparities. The RCC will coordinate activities across all of the chronic disease centers, including data collection; promoting collaboration and communication among investigators and the broader research community; promoting skills development of early stage investigators; coordinating and managing in-person and/or virtual meetings; and facilitating community engagement efforts.

Funding Opportunity RFA-MD-21-007 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support comprehensive research centers on prevention, treatment, and management of multiple chronic diseases associated with associated with health disparities.

Notice NOT-EB-21-006 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-104 from the NIH Guide for Grants and Contracts

Notice NOT-AA-21-024 from the NIH Guide for Grants and Contracts

Notice NOT-AA-21-023 from the NIH Guide for Grants and Contracts